Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 29284010

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
PLoS One
Publication date
2017
First author
O'Neil BH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      O'Neil BH
      type
      Author
    2. name
      Wallmark JM
      type
      Author
    3. name
      Lorente D
      type
      Author
    4. name
      Elez E
      type
      Author
    5. name
      Raimbourg J
      type
      Author
    6. name
      Gomez-Roca C
      type
      Author
    7. name
      Ejadi S
      type
      Author
    8. name
      Piha-Paul SA
      type
      Author
    9. name
      Stein MN
      type
      Author
    10. name
      Abdul Razak AR
      type
      Author
    11. name
      Dotti K
      type
      Author
    12. name
      Santoro A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      O'Neil BH
      type
      Author
    2. name
      Wallmark JM
      type
      Author
    3. name
      Lorente D
      type
      Author
    4. name
      Elez E
      type
      Author
    5. name
      Raimbourg J
      type
      Author
    6. name
      Gomez-Roca C
      type
      Author
    7. name
      Ejadi S
      type
      Author
    8. name
      Piha-Paul SA
      type
      Author
    9. name
      Stein MN
      type
      Author
    10. name
      Abdul Razak AR
      type
      Author
    11. name
      Dotti K
      type
      Author
    12. name
      Santoro A
      type
      Author
    bibliography ids
    1. nci-bib-19abe7fc883dbac14a85736e
    book metadata
    content sha256
    a547b4c7b2a99d6386b77a26c842cd3d523808717515cf201f20fff4a796a23a
    document type
    citation
    dois
    1. 10.1371/journal.pone.0189848
    electronic publication date
    display
    2017 Dec 28
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29284010
    immutable id
    pubmed:29284010@a547b4c7b2a99d6386b77a26c842cd3d523808717515cf201f20fff4a796a23a
    journal
    abbreviation
    PLoS One
    issn electronic
    1932-6203
    issn print
    Source null
    issue
    12
    name
    PloS one
    nlm unique id
    101285081
    pages
    e0189848
    volume
    12
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29284010
      provenance
      batch id
      ec9444d0f4cade22eb9f
      provider
      NCBI PubMed ESummary
      record sha256
      307d066b69f3faf4da029598b39f2537284ee692f9c91ae4c1019e5d898dbefc
      response sha256
      6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
      retrieved at
      2026-09-09T23:47:30.975610+00:00
      publication date
      display
      2017
      precision
      year
      year
      2017
      publication types
      1. Clinical Trial, Phase I
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29284010/
      title
      Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

      Preserved source evidence · Independent clinical review pending · Not medical advice